(Q37142237)

18 August 2017

1 reference

title

The endocannabinoid system: emotion, learning and addiction (English)

1 reference

18 August 2017

main subject

endocannabinoid system

0 references

author name string

Fabrício A Moreira

series ordinal

1

1 reference

18 August 2017

Beat Lutz

series ordinal

2

1 reference

18 August 2017

publication date

16 April 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

13

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

196-212

1 reference

Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

In silico patent searching reveals a new cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Computer analysis and quantification of periaqueductal grey-induced defence behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Evidence for novel cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Hardwiring the brain: endocannabinoids shape neuronal connectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

New approaches to antidepressant drug discovery: beyond monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Anxiolytic-like properties of the anandamide transport inhibitor AM404.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The cannabis withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

THC does not affect striatal dopamine release: Microdialysis in freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Endocannabinoid-mediated synaptic plasticity in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Reward system and addiction: what dopamine does and doesn't do.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Neural systems of reinforcement for drug addiction: from actions to habits to compulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabinoids modulate ultrasound-induced aversive responses in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The endocannabinoid system and neurogenesis in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Being stoned: a review of self-reported cannabis effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Adverse effects of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

An endocannabinoid mechanism for stress-induced analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Psychiatric effects of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Modulation of anxiety through blockade of anandamide hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Drug addiction: pathways to the disease and pathophysiological perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Marijuana and cannabinoid regulation of brain reward circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The endocannabinoid system and extinction learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Aversive effects of the synthetic cannabinoid CP 55,940 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid typ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Study of cannabinoid dependence in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Involvement of the endocannabinoid system in drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Enhancement of endocannabinoid signalling during adolescence: Modulation of impulsivity and long-term consequences on metabolic brain parameters in early maternally deprived rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The endogenous cannabinoid system controls extinction of aversive memories

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Involvement of CB1 cannabinoid receptors in emotional behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The neurobiology and control of anxious states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The endocannabinoid system controls key epileptogenic circuits in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Stimulus-transcription coupling in neurons: role of cellular immediate-early genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

A review of systems and networks of the limbic forebrain/limbic midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The endocannabinoid system as an emerging target of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The molecular logic of endocannabinoid signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

The orphan receptor GPR55 is a novel cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Behavioural assessment of drug reinforcement and addictive features in rodents: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Fear and power-dominance drive motivation: neural representations and pathways mediating sensory and mnemonic inputs, and outputs to premotor structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Biochemistry and pharmacology of endovanilloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Biphasic effects of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Memory reconsolidation and extinction have distinct temporal and biochemical signatures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

A community survey of adverse effects of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Molecular and cellular basis of cannabinoid and opioid interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Endocannabinoid system and stress and anxiety responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Effects of endocannabinoid neurotransmission modulators on brain stimulation reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabis induced dopamine release: an in-vivo SPECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Pain modulation by release of the endogenous cannabinoid anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Endocannabinoid signaling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Forebrain substrates of reward and motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Role of endogenous cannabinoids in cognition and emotionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Two brain sites for cannabinoid reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00104.X

10.1111/J.1369-1600.2008.00104.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference